We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TZA icon
4101
Direxion Daily Small Cap Bear 3x ETF
TZA
$212M
$228K ﹤0.01%
32
-50
-61% -$376K
ONCE
4102
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$228K ﹤0.01%
4,310
+1,425
+49% +$84.6K
UN
4103
DELISTED
Unilever NV New York Registry Shares
UN
$228K ﹤0.01%
4,604
-42,985
-90% -$1.93M
AVA icon
4104
Avista
AVA
$3.23B
$227K ﹤0.01%
5,837
-19,606
-77% -$768K
HLI icon
4105
Houlihan Lokey
HLI
$8.94B
$227K ﹤0.01%
6,591
+6,191
+1,548% +$198K
SPXC icon
4106
SPX Corp
SPXC
$10.9B
$227K ﹤0.01%
9,362
+1,678
+22% +$41.6K
WRLD icon
4107
World Acceptance Corp
WRLD
$907M
$227K ﹤0.01%
4,388
+1,243
+40% +$66.7K
CVBF icon
4108
CVB Financial
CVBF
$4.06B
$226K ﹤0.01%
10,247
+2,073
+25% +$47.4K
DX
4109
Dynex Capital
DX
$3.17B
$226K ﹤0.01%
10,634
+10,262
+2,759% +$210K
ING icon
4110
CALL
ING
ING
$103B
$226K ﹤0.01%
15,000
+9,700
+183% +$142K
LPG icon
4111
Dorian LPG
LPG
$1.86B
$226K ﹤0.01%
21,502
+21,302
+10,651% +$219K
SGMO
4112
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$226K ﹤0.01%
43,283
-2,540
-6% -$10.2K
STM icon
4113
PUT
STMicroelectronics
STM
$47B
$226K ﹤0.01%
+14,600
New +$203K
PVG
4114
DELISTED
PRETIUM RESOURCES INC.
PVG
$226K ﹤0.01%
+21,100
New +$223K
RP
4115
DELISTED
RealPage, Inc.
RP
$226K ﹤0.01%
6,442
+4,306
+202% +$141K
CHUBK
4116
DELISTED
CommerceHub, Inc. Series C Common Stock
CHUBK
$226K ﹤0.01%
14,601
-2,144
-13% -$33.2K
HEOP
4117
DELISTED
Heritage Oaks Bancorp
HEOP
$226K ﹤0.01%
16,975
+110
+0.7% +$1.46K
RGR icon
4118
CALL
Sturm, Ruger & Co
RGR
$613M
$225K ﹤0.01%
4,200
-700
-14% -$35.9K
JACK icon
4119
CALL
Jack in the Box
JACK
$349M
$224K ﹤0.01%
2,200
+1,800
+450% +$186K
BIG
4120
PUT
DELISTED
Big Lots, Inc.
BIG
$224K ﹤0.01%
4,600
+200
+5% +$10.1K
CRCM
4121
DELISTED
CARE.COM, INC.
CRCM
$224K ﹤0.01%
17,948
+17,874
+24,154% +$177K
BSBR icon
4122
Santander
BSBR
$43.5B
$223K ﹤0.01%
26,419
-65
-0.2% -$635
WMK icon
4123
Weis Markets
WMK
$1.83B
$223K ﹤0.01%
3,748
+769
+26% +$47.1K
ZGNX
4124
DELISTED
Zogenix, Inc.
ZGNX
$223K ﹤0.01%
20,574
+2,377
+13% +$24.1K
ITT icon
4125
PUT
ITT
ITT
$18.4B
$222K ﹤0.01%
5,400
+1,000
+23% +$41.1K

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.